Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Ratios

0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Ratios

DE:6NQ's free cash flow for Q2 2026 was zł0.58. For the 2026 fiscal year, DE:6NQ's free cash flow was decreased by zł and operating cash flow was zł<0.01. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	0.87	0.90	1.07	1.47	2.26
Quick Ratio	0.79	0.81	0.85	0.97	1.74
Cash Ratio	<0.01	0.01	0.02	0.07	1.11
Solvency Ratio	-0.04	-0.05	0.09	0.07	0.21
Operating Cash Flow Ratio	>-0.01	0.05	0.32	-0.17	0.12
Short-Term Operating Cash Flow Coverage	>-0.01	0.09	0.74	-0.68	0.43
Net Current Asset Value	zł -59.73M	zł -17.50M	zł -130.96M	zł -107.69M	zł -2.17M
Leverage Ratios
Debt-to-Assets Ratio	0.31	0.28	0.27	0.26	0.09
Debt-to-Equity Ratio	0.76	0.68	0.66	0.62	0.14
Debt-to-Capital Ratio	0.43	0.40	0.40	0.38	0.13
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.32	0.34	0.05
Financial Leverage Ratio	2.48	2.44	2.46	2.36	1.55
Debt Service Coverage Ratio	-0.02	-0.04	0.84	1.36	1.72
Interest Coverage Ratio	-2.52	-5.21	4.00	5.11	11.77
Debt to Market Cap	0.41	0.30	0.24	0.22	0.03
Interest Debt Per Share	1.30	1.22	1.18	1.02	0.24
Net Debt to EBITDA	-15.23	-11.39	3.93	4.56	-0.78
Profitability Margins
Gross Profit Margin	49.60%	30.93%	61.67%	60.00%	56.50%
EBIT Margin	-39.24%	-48.98%	17.76%	14.10%	18.22%
EBITDA Margin	-12.20%	-17.34%	28.23%	25.41%	30.57%
Operating Profit Margin	-38.87%	-48.98%	17.32%	14.75%	19.53%
Pretax Profit Margin	-51.74%	-56.92%	13.44%	11.21%	16.57%
Net Profit Margin	-43.06%	-47.45%	10.52%	8.12%	12.07%
Continuous Operations Profit Margin	-43.06%	-47.45%	10.52%	8.12%	12.07%
Net Income Per EBT	83.22%	83.36%	78.30%	72.43%	72.86%
EBT Per EBIT	133.09%	116.20%	77.60%	75.97%	84.80%
Return on Assets (ROA)	-7.11%	-6.55%	2.53%	1.79%	3.73%
Return on Equity (ROE)	-16.95%	-15.99%	6.22%	4.22%	5.76%
Return on Capital Employed (ROCE)	-11.74%	-12.16%	4.86%	3.68%	7.10%
Return on Invested Capital (ROIC)	-6.31%	-6.83%	3.54%	2.57%	4.92%
Return on Tangible Assets	-7.22%	-6.64%	2.54%	1.79%	3.74%
Earnings Yield	-9.82%	-7.53%	2.37%	1.59%	1.55%
Efficiency Ratios
Receivables Turnover	2.53	1.85	2.01	2.89	3.34
Payables Turnover	8.35	13.34	1.63	8.14	8.08
Inventory Turnover	2.17	2.36	2.83	1.51	1.77
Fixed Asset Turnover	0.31	0.26	0.30	0.28	0.52
Asset Turnover	0.17	0.14	0.24	0.22	0.31
Working Capital Turnover Ratio	-2.95	-8.53	8.07	2.58	1.85
Cash Conversion Cycle	268.78	324.57	86.20	322.61	270.10
Days of Sales Outstanding	144.52	197.58	181.65	126.36	109.19
Days of Inventory Outstanding	167.99	154.35	128.98	241.11	206.09
Days of Payables Outstanding	43.73	27.36	224.43	44.86	45.18
Operating Cycle	312.51	351.93	310.63	367.48	315.28
Cash Flow Ratios
Operating Cash Flow Per Share	>-0.01	0.10	0.19	-0.08	0.05
Free Cash Flow Per Share	-0.20	-0.29	-0.40	-1.68	-0.52
CapEx Per Share	0.20	0.39	0.59	1.60	0.56
Free Cash Flow to Operating Cash Flow	49.88	-2.88	-2.05	22.07	-11.47
Dividend Paid and CapEx Coverage Ratio	-0.02	0.26	0.31	-0.05	0.08
Capital Expenditure Coverage Ratio	-0.02	0.26	0.33	-0.05	0.08
Operating Cash Flow Coverage Ratio	>-0.01	0.09	0.17	-0.08	0.19
Operating Cash Flow to Sales Ratio	>-0.01	0.17	0.19	-0.09	0.06
Free Cash Flow Yield	-7.10%	-7.86%	-8.82%	-39.31%	-8.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-9.89	-13.52	41.09	63.05	64.41
Price-to-Sales (P/S) Ratio	4.40	6.30	4.44	5.12	7.77
Price-to-Book (P/B) Ratio	1.80	2.12	2.62	2.66	3.71
Price-to-Free Cash Flow (P/FCF) Ratio	-14.09	-12.73	-11.34	-2.54	-11.58
Price-to-Operating Cash Flow Ratio	-700.57	36.65	23.22	-56.13	132.85
Price-to-Earnings Growth (PEG) Ratio	-0.03	0.04	0.66	-2.32	1.69
Price-to-Fair Value	1.80	2.12	2.62	2.66	3.71
Enterprise Value Multiple	-51.28	-47.75	19.66	24.70	24.65
Enterprise Value	304.93M	347.79M	398.38M	367.88M	379.70M
EV to EBITDA	-51.28	-47.75	19.66	24.70	24.65
EV to Sales	6.25	8.28	5.55	6.28	7.54
EV to Free Cash Flow	-20.04	-16.71	-14.17	-3.12	-11.23
EV to Operating Cash Flow	-999.79	48.14	29.02	-68.83	128.80
Tangible Book Value Per Share	1.51	2.22	1.70	1.60	1.61
Shareholders’ Equity Per Share	1.57	1.72	1.72	1.60	1.61
Tax and Other Ratios
Effective Tax Rate	0.17	0.17	0.22	0.28	0.27
Revenue Per Share	0.64	0.58	1.02	0.83	0.77
Net Income Per Share	-0.28	-0.27	0.11	0.07	0.09
Tax Burden	0.83	0.83	0.78	0.72	0.73
Interest Burden	1.32	1.16	0.76	0.80	0.91
Research & Development to Revenue	0.00	0.00	0.00	0.00	0.00
SG&A to Revenue	0.84	0.89	0.45	0.31	0.25
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	0.01	-0.36	1.82	-0.81	0.35

Currency in PLN